Product code NUA— Immunology

TAG-IT CYSTIC FIBROSIS KIT

Classification name
System, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Mutation Detection
Device class
Class 2
Regulation
21 CFR 866.5900
Advisory panel
Immunology
Total cleared
12
First cleared
Most recent

FDA classification definition

“The cftr gene mutation detection system is a device used to simultaneously detect and identify a panel of mutations and variants in the cftr gene. It is intended as an aid in confirmatory diagnostic testing of individuals with suspected cystic fibrosis (cf), carrier identification, and newborn screening. This device is not intended for stand-alone diagnostic purposes, prenatal diagnostic, pre-implantation or population screening.”

— U.S. Food and Drug Administration, device classification record for product code NUA under 21 CFR 866.5900, via openFDA

Market context for product code NUA

FDA has cleared 12 devices under product code NUA between 2005 and 2016, filed by 8 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code NUA

Recent clearances under product code NUA

Data sourced from openFDA. This site is unofficial and independent of the FDA.